This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Glaxo Wellcome Inc.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Richard Gordon Buckholz: Innovator in Hepatitis B Surface Antigen Production
Introduction
Richard Gordon Buckholz is an accomplished inventor known for his contributions to biotechnology, particularly in the field of hepatitis B surface antigen production. His innovative work has paved the way for advancements in medical research and vaccine development.
Latest Patents
Richard Gordon Buckholz holds a notable patent titled "Yeast Production Of Hepatitis B Surface Antigen." This patent discloses novel DNA constructs that comprise regulatory regions along with the structural coding region for hepatitis B surface antigen (HBsAg). The constructs are designed to respond to various carbon sources, enabling the production and isolation of HBsAg in high yields.
Career Highlights
Buckholz has had a significant career at Phillips Petroleum Company, where he has applied his expertise in biotechnology. His work has contributed to the understanding and production of important medical antigens, showcasing his commitment to innovation in the field.
Collaborations
Throughout his career, Richard has collaborated with esteemed colleagues such as Juerg Friedrich Tschopp and Michael Miller Harpold. These partnerships have further enhanced the impact of his research and innovations.
Conclusion
Richard Gordon Buckholz's contributions to the field of biotechnology, particularly in hepatitis B surface antigen production, highlight his role as an innovator. His work continues to influence medical research and vaccine development, underscoring the importance of his inventions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile